Sultamicillin
- Generic Name
- Sultamicillin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H30N4O9S2
- CAS Number
- 76497-13-7
- Unique Ingredient Identifier
- 65DT0ML581
- Background
Sultamicillin has been used in trials studying the prevention and treatment of Ventilator Associated Pneumonia and Chronic Obstructive Pulmonary Disease (COPD).
- Indication
本品适用于产β内酰胺酶的葡萄球菌属、大肠埃希菌、克雷伯菌属、奇异变形杆菌、不动杆菌属和脆弱拟杆菌等敏感菌所致的以下感染：1.鼻窦炎、中耳炎、扁桃体炎等上呼吸道感染；2.支气管炎、肺炎等下呼吸道感染；3.尿路感染；4.皮肤、软组织感染；5.淋病奈瑟菌感染。本品还可用于氨苄西林舒巴坦注射给药的后续治疗。
- Associated Conditions
- Severe Bacterial Infections caused by Beta lactamase producing bacteria
- Associated Therapies
- -
Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-07-04
- Last Posted Date
- 2020-06-05
- Lead Sponsor
- Hannover Medical School
- Target Recruit Count
- 295
- Registration Number
- NCT01892488
- Locations
- 🇩🇪
Schwerpunktpraxis Colonnaden Hamburg, Hamburg, Germany
🇩🇪Diakoniekrankenhaus Rotenburg, Rotenburg, Germany
🇩🇪Krankenhaus Bethanien Solingen, Solingen, Germany
Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2016-05-24
- Lead Sponsor
- Hospital Pablo Tobón Uribe
- Registration Number
- NCT01118403
- Locations
- 🇨🇴
Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath